Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

IntroductionHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It arises from ...

A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

A New Hope? Russia has developed a therapeutic cancer vaccine, which means it won’t prevent cancer but aims to cure it.

St. David’s Medical Center in Austin is the first hospital in Central Texas to offer histotripsy, a noninvasive ultrasound ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...

Liver, and head and neck cancers are more prevalent in Asia, highlighting the need for improved understanding and treatment options here.

Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health ...